Amarin Corporation(AMRN)
Search documents
Amarin Corporation(AMRN) - 2021 Q2 - Earnings Call Transcript
2021-08-05 17:29
Amarin Corporation plc (NASDAQ:AMRN) Q2 2021 Earnings Conference Call August 5, 2021 7:30 AM ET Company Participants Michael Kalb - Chief Financial Officer Karim Mikhail - President and Chief Executive Officer Conference Call Participants Ken Cacciatore - Cowen Yasmeen Rahimi - Piper Sandler Louise Chen - Cantor Fitzgerald Dennis Ding - Jefferies Group LLC Jessica Fye - J.P. Morgan Operator Welcome to Amarin Corporation's conference call to discuss its Second Quarter and Six Months 2021 Financial Results an ...
Amarin Corporation plc (AMRN) CEO John Thero Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)
2021-06-08 17:59
Amarin Corporation plc (NASDAQ:AMRN) Goldman Sachs 42nd Annual Global Healthcare Conference June 8, 2021 10:30 AM ET Company Participants John Thero - CEO Karim Mikhail - SVP, Commercial Head Europe Conference Call Participants Paul Choi - Goldman Sachs Paul Choi Good morning. We'll continue with the next session. I'm Paul Choi, SMid-Cap biotechnology analyst here at Goldman Sachs. It's my pleasure to introduce the management team from Amarin. With us today, we have John Thero and Karim Mikhail. What we'll ...
Amarin Corporation(AMRN) - 2020 Q3 - Quarterly Report
2020-11-05 11:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-21392 Amarin Corporation plc (Exact Name of Registrant as Specified in its Charter) England and Wales Not applicable (State or Other Juris ...
Amarin Corporation(AMRN) - 2020 Q2 - Quarterly Report
2020-08-04 10:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-21392 Amarin Corporation plc (Exact Name of Registrant as Specified in its Charter) England and Wales Not applicable (State or Other Jurisdicti ...